- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00374972
Combined Hormonal Versus Progestin Only Contraception During Lactation
Objective: To determine and compare the effect of low dose estrogen combined hormonal contraceptives and progestin-only contraceptives on lactation.
The subjects will be drawn from a healthy obstetric population in each center, where possible preliminary contact during antenatal period. At the postpartum visit, subjects that express their wish for a hormonal contraceptive method will be offered enrollment. After obtaining an informed consent the participants will be allocated according to their free wish to either receive a combined preparation containing 0.02 mg ethylestradiol and 0.15 mg desogestrel (Mercilon, Organon) or a progestin only pill containing 0.075 mg desogestrel (Cerazette, Organon). Demographic, habits and perinatal data will be collected and stored to analysis.
Frequency and methods of observation: All women will be followed at 6 (baseline), 9 and 12 weeks post - partum. Instruction will be given as to recording information on intercurrent disease, frequency of nursing and use of complementary formula supplements. Maternal BMI calculation ( weight/height2) will be obtained at first visit.
The objective is to compare the capacity of the breast to secrete milk under standard conditions and evaluate the influence of different hormonal contraception means. Thus samples will be collected at 6 weeks (enrollment) and the 9 and 12 weeks visits. An Egnell pump will be used for a maximum of 20 minutes form from both breasts, simulating a regular breast feeding. A total of 10 ml aliquot will be taken for composition analysis and the rest will be offered to the infant. The milk volume/feeding will be estimated and expressed in ml/feeding and multiplied by the number of feedings reported.
Outcome variables: Milk volume, infant growth at each visit and biochemical markers of milk analysis : lipid, casein and carbohydrate content
Study Overview
Status
Conditions
Study Type
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy
Exclusion Criteria:
- mothers to infants that their weight will be below the 10th percentile
- mothers to infants sensitive to milk
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
combined contraceptives
|
pregesterone only contraceptives
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Naama Srebnik, MD, A resident at the Shaare Zedek Medical Center
- Study Director: Surina Grisaru-Granovsky, A senior doctor at the Shaare Zedek Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 40106
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lactation
-
ArdelyxRecruiting
-
Medela AGCompleted
-
Medela AGCompleted
-
Massachusetts General HospitalCompleted
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of VirginiaUniversity of North CarolinaCompleted
-
Medela AGCompleted
-
Medela AGCompleted